Extensive biliary excretion of the model opioid peptide [D-PEN(2,5)] enkephalin in rats

被引:28
作者
Chen, CP [1 ]
Pollack, GM [1 ]
机构
[1] UNIV N CAROLINA,SCH PHARM,DIV PHARMACEUT,CHAPEL HILL,NC 27599
关键词
DPDPE; opioid peptide; biliary excretion; CZE;
D O I
10.1023/A:1012054222845
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. This study was designed to test the hypothesis that the enzymatically stable opioid peptide, [D-pen(2,5)] enkephalin (DPDPE), is excreted extensively into bile. Methods. Following an i.v. bolus dose of DPDPE (10 mg/kg) to rats, concentrations of DPDPE in serum, bile, liver homogenate and urine were measured by a novel capillary zone electrophoresis method. Data were analyzed to recover the fundamental pharmacokinetic parameters (volumes of distribution; distribution and elimination rate constants governing DPDPE systemic and biliary disposition). Parallel in vitro experiments were performed to evaluate the partitioning of DPDPE between erythrocytes and plasma, as well as to assess the degree of binding of DPDPE to serum proteins. Results. The majority of the administered dose (similar to 80%) was recovered from bile as intact peptide. DPDPE disposition was best described by a two-compartment model with Michaelis-Menten elimination (K-m: 37.5 +/- 11 mu g/ml; V-max: 1143 +/- 368 mu g/min/kg) from the central compartment into bile, suggestive of an active hepatic transport system. DPDPE was associated with a distributional space of 486 +/- 62 ml/kg. In vitro incubation of DPDPE with whole blood showed that similar to-65% of the peptide was associated with erythrocytes. The difference between concentrations of DPDPE in erythrocytes and plasma was statistically significant (29.2 +/- 4.9 vs. 18.1 +/- 3.1 mu g/ml, p < 0.05), but not between whole blood and plasma (21.3 +/- 2.8 vs. 18.1 +/- 3.1 mu g/ml, p > 0.05). Concentration-independent binding of DPDPE to serum proteins was evidenced between 10 and 100 mu g/ml, with an unbound fraction of 0.517 +/- 0.182. Conclusions. DPDPE undergoes extensive biliary excretion after i.v administration in rats. The apparent nonlinearity in the biliary excretion of DPDPE revealed by the pharmacokinetic modeling strongly suggests the existence of an active transport system(s) in hepatocytes which may mediate the rapid disappearance of DPDPE from the systemic circulation.
引用
收藏
页码:345 / 350
页数:6
相关论文
共 20 条
  • [1] SDZ-CO-611 - A HIGHLY POTENT GLYCATED ANALOG OF SOMATOSTATIN WITH IMPROVED ORAL ACTIVITY
    ALBERT, R
    MARBACH, P
    BAUER, W
    BRINER, U
    FRICKER, G
    BRUNS, C
    PLESS, J
    [J]. LIFE SCIENCES, 1993, 53 (06) : 517 - 525
  • [2] PERMEABILITY OF THE MURINE BLOOD-BRAIN-BARRIER TO SOME OCTAPEPTIDE ANALOGS OF SOMATOSTATIN
    BANKS, WA
    SCHALLY, AV
    BARRERA, CM
    FASOLD, MB
    DURHAM, DA
    CSERNUS, VJ
    GROOT, K
    KASTIN, AJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6762 - 6766
  • [3] BOUER W, 1982, LIFE SCI, V31, P1133
  • [4] Development of a capillary zone electrophoresis assay to examine the disposition of [D-pen(2,5)]enkephalin in rats
    Chen, CP
    Pollack, GM
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 681 (02): : 363 - 373
  • [5] GREENFIELD JC, 1989, DRUG METAB DISPOS, V17, P518
  • [6] REACTION OF OPIOID-PEPTIDES WITH NEUTRAL ENDOPEPTIDASE (ENKEPHALINASE)
    HERSH, LB
    [J]. JOURNAL OF NEUROCHEMISTRY, 1984, 43 (02) : 487 - 493
  • [7] KHAN BD, 1983, TRANSPLANT P, V15, P2469
  • [8] LEMAIRE M, 1989, DRUG METAB DISPOS, V17, P699
  • [9] FACTORS INFLUENCING THE PHARMACOKINETICS OF CYCLOSPORINE IN MAN
    LINDHOLM, A
    [J]. THERAPEUTIC DRUG MONITORING, 1991, 13 (06) : 465 - 477
  • [10] BIS-PENICILLAMINE ENKEPHALINS POSSESS HIGHLY IMPROVED SPECIFICITY TOWARD DELTA-OPIOID RECEPTORS
    MOSBERG, HI
    HURST, R
    HRUBY, VJ
    GEE, K
    YAMAMURA, HI
    GALLIGAN, JJ
    BURKS, TF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (19): : 5871 - 5874